logo

For the Inventor, By the Inventor

Wilmington, DE, United States of America

Jenrin Discovery, Inc.


USPTO Granted Patents = 27

% Expired Patents = 51.9



Forward Citations = 174

Loading Chart...
Loading Chart...

5 inventors (with patents filed for the assignee):

goldMedal Robert J Chorvat (27 out of 48 patents)

silverMedal John Francis McElroy (27 out of 33 patents)

bronzeMedal Parthasarathi Rajagopalan (2 out of 13 patents)

4.  Rajagopalan Parthasarathi (2 out of 2 patents)

5.  David Nugiel (1 out of 7 patents)

6.  John Mcelroy (0 patent)

7.  John F Mcelroy (0 patent)

8.  John Mcelroy (0 patent)

9.  John Mcelroy (0 patent)

10.  John F Mcelroy (0 patent)


27 patents:

1. 11179370 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2021-11-23),
2. 10617673 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2020-04-14),
3. 9987253 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2018-06-05),
4. 9517228 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2016-12-13),
5. 9133127 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2015-09-15),
6. 8853252 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2014-10-07),
7. 8716265 - 4-quinolinemethanols as anti-malarial agents (2014-05-06),
8. 8680131 - Cannabinoid receptor antagonists/inverse agonists useful for treating disease conditions, including metabolic disorders and cancers (2014-03-25),
9. 8648072 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2014-02-11),
10. 8580768 - Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2013-11-12),
11. 8541475 - MAO-B inhibitors useful for treating obesity (2013-09-24),
12. 8334282 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2012-12-18),
13. 8252791 - Purine compounds as cannabinoid receptor blockers (2012-08-28),
14. 8236821 - Substituted N-phenyl-5-phenyl-pyrazolin-3-yl amides as cannabinoid receptor antagonists/inverse agonists useful for treating obesity (2012-08-07),
15. 8217038 - Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes (2012-07-10),
JENRIN DISCOVERY, INC. is a tech startup specializing in cutting-edge research and development in the field of biotechnology. With a dedicated team of scientists and engineers, we aim to deliver innovative solutions and advancements in drug discovery. Our mission is to revolutionize the pharmaceutical industry through the discovery of novel therapies and treatments for various diseases. Visit our website to learn more about our groundbreaking projects and collaborations.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

27 Patents

#171 in Wilmington, DE

#206 in Delaware

#12,394 in US

#23,935 in the World

Wilmington, DE (US)
Wilmington, DE, United States of America

Jenrin Discovery, Inc.

Forward Citations = 174

5 inventors:

goldMedal Robert J Chorvat (27 out of 48 patents)

silverMedal John Francis McElroy (27 out of 33 patents)

bronzeMedal Parthasarathi Rajagopalan (2 out of 13 patents)

4.  Rajagopalan Parthasarathi (2 out of 2 patents)

5.  David Nugiel (1 out of 7 patents)

Please report any incorrect information to [email protected]
Loading…